Wen Xu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Cancer-related gene regulation
Papers in
-
- RNA modifications and cancer 21
- Circular RNAs in diseases 11
- Advanced biosensing and bioanalysis techniques 10
- RNA Interference and Gene Delivery 10
- Cancer-related gene regulation 8
-
- Cancer-related molecular mechanisms research 24
- MicroRNA in disease regulation 15
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Bin Li (16 shared papers)Qing‐Yu He (11 shared papers)Pan Ran (9 shared papers)Xin‐Yuan Guan (6 shared papers)Sai Wah Tsao (6 shared papers)Annie L.M. Cheung (5 shared papers)Simon Law (7 shared papers)Can‐Can Zheng (7 shared papers)
In The Last Decade
Wen Xu
83 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 127
- Cancer Research 823
- Molecular Biology 1.4k
- Oncology 282
- Immunology 163
- Cell Biology 112
Countries citing papers authored by Wen Xu
This map shows the geographic impact of Wen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Xu more than expected).
Fields of papers citing papers by Wen Xu
This network shows the impact of papers produced by Wen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Xu. The network helps show where Wen Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wen Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 106 | |
| 2 | 2014 | 103 | |
| 3 | 2018 | 90 | |
| 4 | 2017 | 81 | |
| 5 | 2020 | 70 | |
| 6 | Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer. | 2019 | 68 |
| 7 | 2021 | 66 | |
| 8 | 2014 | 61 | |
| 9 | 2021 | 60 | |
| 10 | 2014 | 51 | |
| 11 | 2000 | 49 | |
| 12 | 2019 | 49 | |
| 13 | 2023 | 48 | |
| 14 | 2020 | 42 | |
| 15 | 2018 | 41 | |
| 16 | 2014 | 36 | |
| 17 | 2019 | 35 | |
| 18 | 2021 | 35 | |
| 19 | 2016 | 34 | |
| 20 | 2021 | 33 |
About Wen Xu
Wen Xu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 87 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (24 papers), RNA modifications and cancer (21 papers), MicroRNA in disease regulation (15 papers), Circular RNAs in diseases (11 papers), Advanced biosensing and bioanalysis techniques (10 papers), RNA Interference and Gene Delivery (10 papers), Cancer-related gene regulation (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Cancer Research (823 citations), Molecular Biology (1.4k citations), Oncology (282 citations), Immunology (163 citations) and Cell Biology (112 citations). Wen Xu has collaborated with scholars based in China, Hong Kong and Canada. Frequent co-authors include Bin Li, Qing‐Yu He, Pan Ran, Xin‐Yuan Guan, Sai Wah Tsao, Annie L.M. Cheung, Simon Law, Can‐Can Zheng, Chengfu Yuan and Bei Wang. Their work appears in journals such as Current Pharmaceutical Design, Oncotarget, Aging, Current Medicinal Chemistry and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.